Sarepta Therapeutics (SRPT) Gains on Coverage Update

October 12, 2016 10:36 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Sarepta Therapeutics (NASDAQ: SRPT) active as Anthem is said to be out positive now on Etep coverage.

Link (doc)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment